前哮喘:一个有用的概念?EUFOREA 的论文。第二部分--晚发嗜酸性粒细胞性哮喘

IF 3.3 Q2 ALLERGY
G. Scadding, C. Gray, D. M. Conti, M. McDonald, V. Backer, G. Scadding, M. Bernal-Sprekelsen, E. De Corso, Z. Diamant, C. Hopkins, M. Jesenak, P. Johansen, J. Kappen, J. Mullol, D. Price, S. Quirce, S. Reitsma, S. Toppila-Salmi, B. Senior, J. P. Thyssen, U. Wahn, P. Hellings
{"title":"前哮喘:一个有用的概念?EUFOREA 的论文。第二部分--晚发嗜酸性粒细胞性哮喘","authors":"G. Scadding, C. Gray, D. M. Conti, M. McDonald, V. Backer, G. Scadding, M. Bernal-Sprekelsen, E. De Corso, Z. Diamant, C. Hopkins, M. Jesenak, P. Johansen, J. Kappen, J. Mullol, D. Price, S. Quirce, S. Reitsma, S. Toppila-Salmi, B. Senior, J. P. Thyssen, U. Wahn, P. Hellings","doi":"10.3389/falgy.2024.1404735","DOIUrl":null,"url":null,"abstract":"The concept of pre-diabetes has led to provision of measures to reduce disease progression through identification of subjects at risk of diabetes. We previously considered the idea of pre-asthma in relation to allergic asthma and considered that, in addition to the need to improve population health via multiple measures, including reduction of exposure to allergens and pollutants and avoidance of obesity, there are several possible specific means to reduce asthma development in those most at risk (pre- asthma). The most obvious is allergen immunotherapy (AIT), which when given for allergic rhinitis (AR) has reasonable evidence to support asthma prevention in children (2) but also needs further study as primary prevention. In this second paper we explore the possibilities for similar actions in late onset eosinophilic asthma.","PeriodicalId":73062,"journal":{"name":"Frontiers in allergy","volume":null,"pages":null},"PeriodicalIF":3.3000,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pre-asthma: a useful concept? A EUFOREA paper. Part 2—late onset eosinophilic asthma\",\"authors\":\"G. Scadding, C. Gray, D. M. Conti, M. McDonald, V. Backer, G. Scadding, M. Bernal-Sprekelsen, E. De Corso, Z. Diamant, C. Hopkins, M. Jesenak, P. Johansen, J. Kappen, J. Mullol, D. Price, S. Quirce, S. Reitsma, S. Toppila-Salmi, B. Senior, J. P. Thyssen, U. Wahn, P. Hellings\",\"doi\":\"10.3389/falgy.2024.1404735\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The concept of pre-diabetes has led to provision of measures to reduce disease progression through identification of subjects at risk of diabetes. We previously considered the idea of pre-asthma in relation to allergic asthma and considered that, in addition to the need to improve population health via multiple measures, including reduction of exposure to allergens and pollutants and avoidance of obesity, there are several possible specific means to reduce asthma development in those most at risk (pre- asthma). The most obvious is allergen immunotherapy (AIT), which when given for allergic rhinitis (AR) has reasonable evidence to support asthma prevention in children (2) but also needs further study as primary prevention. In this second paper we explore the possibilities for similar actions in late onset eosinophilic asthma.\",\"PeriodicalId\":73062,\"journal\":{\"name\":\"Frontiers in allergy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2024-05-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in allergy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3389/falgy.2024.1404735\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ALLERGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/falgy.2024.1404735","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

摘要

糖尿病前期的概念促使人们采取措施,通过识别糖尿病高危人群来减少疾病的发展。我们曾考虑过与过敏性哮喘有关的哮喘前期概念,并认为除了需要通过多种措施(包括减少接触过敏原和污染物以及避免肥胖)来改善人群健康外,还有几种可能的具体方法来减少高危人群(哮喘前期)的哮喘发展。最明显的是过敏原免疫疗法(AIT),这种疗法用于治疗过敏性鼻炎(AR)时,有合理的证据支持预防儿童哮喘(2),但作为一级预防还需要进一步研究。在第二篇论文中,我们探讨了在晚发性嗜酸性粒细胞哮喘中采取类似措施的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Pre-asthma: a useful concept? A EUFOREA paper. Part 2—late onset eosinophilic asthma
The concept of pre-diabetes has led to provision of measures to reduce disease progression through identification of subjects at risk of diabetes. We previously considered the idea of pre-asthma in relation to allergic asthma and considered that, in addition to the need to improve population health via multiple measures, including reduction of exposure to allergens and pollutants and avoidance of obesity, there are several possible specific means to reduce asthma development in those most at risk (pre- asthma). The most obvious is allergen immunotherapy (AIT), which when given for allergic rhinitis (AR) has reasonable evidence to support asthma prevention in children (2) but also needs further study as primary prevention. In this second paper we explore the possibilities for similar actions in late onset eosinophilic asthma.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.80
自引率
0.00%
发文量
0
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信